Discover Cutting-Edge Clinical Trials

If you or a family member 18 years of age or older has been diagnosed with cancer of the throat or mouth, you may qualify for a clinical trial and will receive study treatment and compensation. Please click on the link below for more information:

We are enrolling participants 18 and older in a clinical study for Multiple Myeloma. To qualify, you must:

• Have been diagnosed with Multiple Myeloma

• Have received at least 1 prior line of anti-myeloma therapy

• Have documented evidence of progressive disease on or after the last regimen

Participants may receive compensation and study treatment.

Please contact us for more information.

If you are 18 years of age or older and have been newly diagnosed with Chronic Myeloid Leukemia or have received prior treatment with imatinib, or nilotinib, or dasatinib or bosutinib for 4 weeks or less, you may qualify for a clinical study.

You may qualify for this clinical trial if you have been diagnosed with non small cell lung cancer and have not progressed following concurrent chemoradiation therapy.

You may be eligible for treatment in clinical trials if you have been diagnosed with locally advanced/metastatic solid tumors and/or positive for any of the following biomarkers including:

• MDM2 amplification 
• TP53 
• ALK 
• ROS1

You may qualify for a prostate cancer clinical trial if you have been diagnosed with prostate cancer.

• Have a positive biomarker of CHEK1 that has been confirmed by a provider
• Have failed prior treatment of with a new hormornal agent

You may be eligible for a clinical trial treatment if you have been diagnosed with any of the following cancers and is a high-grade serous:

• Ovarian cancer
• Primary Peritoneal cancer
• Fallopian Tube cancer 

You may be eligible for a central nervous system clinical trial if your provider has diagnosed you with CNS cancer and your cancer has harboring BRAF gene alterations.